These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6646771)

  • 1. The effect of reduced viewing time on colour vision in normal subjects and those with abnormal ocular conditions.
    Taylor S
    Ophthalmic Physiol Opt; 1983; 3(3):357-60. PubMed ID: 6646771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of restricted viewing time on the performance of colour defectives using the City University Colour Vision Test.
    Taylor SP
    Ophthalmic Physiol Opt; 1984; 4(1):49-52. PubMed ID: 6608714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A differential color flicker test for detecting acquired color vision impairment in multiple sclerosis and diabetic retinopathy.
    Gregori B; Papazachariadis O; Farruggia A; Accornero N
    J Neurol Sci; 2011 Jan; 300(1-2):130-4. PubMed ID: 20875905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual acuity and colour vision tests--a preliminary report.
    Williams CM
    Br J Physiol Opt; 1976; 31(4):29-31. PubMed ID: 1053022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Color vision defect type and spatial vision in the optic neuritis treatment trial.
    Schneck ME; Haegerstrom-Portnoy G
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2278-89. PubMed ID: 9344351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatic discrimination losses in multiple sclerosis patients with and without optic neuritis using the Cambridge Colour Test.
    Moura AL; Teixeira RA; Oiwa NN; Costa MF; Feitosa-Santana C; Callegaro D; Hamer RD; Ventura DF
    Vis Neurosci; 2008; 25(3):463-8. PubMed ID: 18598419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of the human visual system to variable illuminant conditions: an analysis of opponent-colour mechanisms in colour constancy.
    Nieves JL; García-Beltrán A; Romero J
    Ophthalmic Physiol Opt; 2000 Jan; 20(1):44-58. PubMed ID: 10884929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatic and luminance losses with multiple sclerosis and optic neuritis measured using dynamic random luminance contrast noise.
    Flanagan P; Zele AJ
    Ophthalmic Physiol Opt; 2004 May; 24(3):225-33. PubMed ID: 15130171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of vision and pupil responses in optic neuritis and multiple sclerosis.
    Moro SI; Rodriguez-Carmona ML; Frost EC; Plant GT; Barbur JL
    Ophthalmic Physiol Opt; 2007 Sep; 27(5):451-60. PubMed ID: 17718884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectral sensitivities of acquired color defects analyzed in terms of color opponent theory.
    Zisman F; King-Smith PE; Bhargava SK
    Mod Probl Ophthalmol; 1978; 19():254-7. PubMed ID: 310041
    [No Abstract]   [Full Text] [Related]  

  • 11. Colour constancy and conscious perception of changes of illuminant.
    Barbur JL; Spang K
    Neuropsychologia; 2008 Feb; 46(3):853-63. PubMed ID: 18206187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive plasticity during the development of colour vision.
    Wagner HJ; Kröger RH
    Prog Retin Eye Res; 2005 Jul; 24(4):521-36. PubMed ID: 15845347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired colour defects under restricted viewing time: a new diagnostic technique?
    Taylor SP
    Br J Ophthalmol; 1984 Feb; 68(2):139-43. PubMed ID: 6691958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of colour vision deficiencies in melanoma patients: results of a prospective comparative screening study with the Farnsworth panel D 15 test including 300 melanoma patients and 100 healthy controls.
    Pföhler C; Tschöp S; König J; Rass K; Tilgen W
    Melanoma Res; 2006 Oct; 16(5):413-21. PubMed ID: 17013090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A time induced tritan defect.
    Taylor SP
    Vision Res; 1983; 23(7):745-8. PubMed ID: 6604364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technical note: the effect of refractive blur on colour vision evaluated using the Cambridge Colour Test, the Ishihara Pseudoisochromatic Plates and the Farnsworth Munsell 100 Hue Test.
    Thyagarajan S; Moradi P; Membrey L; Alistair D; Laidlaw H
    Ophthalmic Physiol Opt; 2007 May; 27(3):315-9. PubMed ID: 17470246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colour contrast sensitivity in patients with age-related Bruch's membrane changes.
    Holz FG; Gross-Jendroska M; Eckstein A; Hogg CR; Arden GB; Bird AC
    Ger J Ophthalmol; 1995 Nov; 4(6):336-41. PubMed ID: 8751098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of pupil responses to luminance and colour in severe optic neuritis.
    Barbur JL; Moro S; Harlow JA; Lam BL; Liu M
    Clin Neurophysiol; 2004 Nov; 115(11):2650-8. PubMed ID: 15465455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Color vision in diabetics].
    Apostol S; Cârstocea B
    Oftalmologia; 1994; 38(1):17-22. PubMed ID: 8155614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal contrast sensitivity in optic neuritis and amblyopia.
    Kayazawa F; Yamamoto T; Itoi M
    Ann Ophthalmol; 1983 Apr; 15(4):331-4. PubMed ID: 6660704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.